ATL Technology Expands Operations in Costa Rica

Lucida Medical (Cambridge University Spin-out) Joins GE Healthcare Edison™ Accelerator Programme

Lucida Medical was invited to join the Edison Accelerator programme for its pioneering work in helping identify prostate cancer and its exceptional development team led by Prof Evis Sala and Dr Antony Rix, both highly experienced in artificial intelligence, or AI, medical technology.

Boston Scientific Exercises Option to Acquire Farapulse, Inc.

FARAPULSE Pulsed Field Ablation (PFA) System is a non-thermal ablation system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias.  

ATL Technology, an interconnect development and manufacturing partner of top medical device firms, today announced the expansion of its Costa Rica operations and the divestiture of its Catheter Research Inc. (“CRI”) business unit to Biomerics.

ATL Technology Brad Brown and CEO notes, “With the increase in interconnect manufacturing demand in Costa Rica, we wanted to put ourselves in a better position to serve our customers and live our mission of bringing impactful medical devices to market. This expansion will help us do that.”

The expansion, which will add over 9,000 sq. ft. of manufacturing space, is one step in the company’s Technology strategic Costa Rica growth plan.

The company has been operating in Costa Rica since 2013. Since that time, the operations have grown to include over 85 employees and 22,000 sq. ft. of manufacturing space, helping supply some of the top medical device companies in the world with cutting-edge interconnect solutions.

This announcement comes on the heels of their decision to divest its CRI business unit.

CRI, a manufacturer of interventional catheters and medical device assemblies with locations in Costa Rica and Indiana, was purchased by the company in a joint venture with Biomerics in 2018.

“Acquiring and running CRI enabled us to learn some valuable lessons about catheter development and manufacturing, which we can use to help our customers moving forward,” explained Brad. “We plan on investing the proceeds from the sale in our internal R&D and growth initiatives.”

To celebrate the Costa Rica expansion, ATL will be hosting an open house on Friday, January 24. The open house will be by invitation only.

The company will also be discussing the plant expansion, the future of interconnect systems, and the latest medical device technology at its exclusive event, #BeyondWest, at MD&M West in February. To enter for your chance to attend

spot_img

DON'T MISS

Trinity Health Names Mark LePage, M.D., as Senior Vice President of Medical Groups and Ambulatory Strategy

Prior to his time at IHA, LePage served as chief medical officer of Marshfield Clinic in Wisconsin

Jody Crane, MD Recognized by Modern Healthcare As One of the 50 Most Influential Clinical Executives

Dr. Crane’s work to streamline operations positioned and prepared TeamHealth and its clinicians to face the COVID-19 pandemic. Under Dr. Crane’s leadership, TeamHealth was able to maintain high levels of clinical quality throughout the rapidly changing COVID environment.

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

Subscribe to Medical Device News Magazine here.

Related Articles